Læknablaðið : fylgirit - 05.01.2015, Qupperneq 43

Læknablaðið : fylgirit - 05.01.2015, Qupperneq 43
X V I I V Í S I N D A R Á Ð S T E F N A H Í F Y L G I R I T 8 2 LÆKNAblaðið/Fylgirit 82 2015/101 43 toxicity. In this model there is an upregulation of proteolysis, suggesting that the mutant protein leads to increase in proteolysis as a defense mechanisms. E 113 Residence in early life and risk of breast cancer Álfheiður Haraldsdóttir1,2, Jóhanna Eyrún Torfadóttir1,2, Unnur A. Valdimarsdóttir1,3, Thor Aspelund1,4, Laufey Tryggvadóttir5,6, Vilmundur Guðnason4,6, Laufey Steingrímsdóttir2 1Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, 2Unit for Nutrition Research, Faculty for Food Science and Nutrition, University of Iceland, 3Department of Epidemiology, Harvard School of Public Health, 4The Icelandic Heart Association, 5The Icelandic Cancer Registry, 6Faculty of Medicine, University of Iceland alh1@hi.is Introduction: During the first half of the 20th century, considerable differences existed in food choice between residential areas in Iceland. Our aim was to explore the effect of residence during early life, including the period when the mammary gland is undergoing rapid development in puberty, on the risk of breast cancer later in life. Methods and data: We used data from the Reykjavik Study, a popula- tion-based Icelandic cohort of 10049 women born between 1907 and 1935, all residing in the capital area in 1967. Participants provided in- formation on residence (capital area, coastal village or rural area) in early life. By linkage with the Icelandic Cancer Registry, information on breast cancer diagnoses was available throughout 2013. Adjustments were made for age, education, body mass index, menarche age, number of total pregnancies and age at first childbirth. For statistical analysis, we used Cox proportional hazard regression models to analyze the risk of breast cancer in women raised in capital area, compared with women raised in coastal villages and rural areas. Results: During a mean follow-up of 27.3 years, 744 women were di- agnosed with breast cancer. We found that women who were born 1921- 1935, and raised in a coastal village (mean duration of residence 20.3 years) had 23% less risk developing breast cancer (hazard ratio = 0.77 95% CI: 0.60 - 0.97), compared with early residence in the capital area. Conclusions: Our results suggest that being raised in a coastal village during adolescence may be associated with reduced risk of breast cancer. E 114 Long-term health effects following the Eyjafjallajökull volcanic eruption: A follow-up study Heiðrún Hlöðversdóttir1,Guðrún Pétursdóttir2, Arna Hauksdóttir1 1Centre of Public Health Sciences, University of Iceland, 2Institute for Sustainability Studies and Faculty of Nursing, University of Iceland heh28@hi.is Introduction: It is estimated that at least 500 million people live within the potential exposure range of a historically active volcano. Studies on long-term effects of volcanic eruptions on health are limited. We aimed to examine the association between a long-term exposure to volcanic ash and physical and mental health. Methods and data: The study design is a longitudinal population-based cohort of individuals exposed to the Eyjafjallajökull eruption and an unexposed reference group from Skagafjörður. Participants answered a questionnaire in 2010 and again in 2013, on physical and psychological symptoms. Logistic regression was used to examine the association between the time after the volcanic eruption in the exposed region in 2013 and 2010 as the reference category, and physical and psychological symptoms. Results: Preliminary results indicate that likelihood of having symp- toms during the last month was higher in the exposed group in 2013 compared to 2010. Phlegm (OR 1.87; 95% CI 1.10 to 3.25), skin rash/ eczema (OR 3.10; 95% CI 1.63 to 6.18) and myalgia (OR 1.56; 95% CI 1.02 to 2.40). During the last 12 months these respiratory symptoms were likelier in the exposed group in 2013; morning winter phlegm (OR 2.20; 95% CI 1.38 to 3.53), nocturnal or daytime winter phlegm (OR 1.82; 95% CI 1.03 to 3.27) and allergic rhinitis (OR 1.72; 95% CI 1.06 to 2.84). Conclusions: Preliminary results imply long-term respiratory health effects after the eruption in Eyjafjallajökull. Ongoing data analysis will also focus on differences in groups by level of exposure, and effects on psychological health. E 115 Dánartíðni vegna krabbameina og annarra dánarmeina meðal notenda jarðhitavatns: Lýðgrunduð hóprannsókn Aðalbjörg Kristbjörnsdóttir1, Vilhjálmur Rafnsson2 1Miðstöð í lýðheilsuvísindum Háskóla Íslands, 2rannsóknastofu í heilbrigðisfræði, læknadeild addab@simnet.is Inngangur: Fyrri rannsóknir á íbúum á háhitasvæðum og jarðhitaveitu- svæðum hafa sýnt aukna áhættu á brjóstakrabbameini, blöðruhálskirt- ilskrabbameini, nýrnakrabbameini og eitilæxlum öðrum en Hodgkin’s. Tilgangur rannsóknarinnar var að greina hvort þessi aukna áhætta endurspeglist einnig í dánarmeinum á meðal íbúa sem nota jarðhitavatn til húshitunar, þvotta og baða. Efniviður og aðferðir: Rannsóknarhópurinn voru einstaklingar á aldr- inum 5-64 ára úr manntalinu frá 1981 og þeim var fylgt eftir frá 1981 til 2009. Allar samkeyrslur gagna voru byggðar á kennitölum. Útsetti hópurinn voru einstaklingar, búsettir í manntali á svæðum þar sem jarðhitavatn hefur verið notað síðan fyrir 1972 og aldur berggrunns er yngri en 0,8 milljón ára. Samanburðarhópar voru valdir eftir mismun- andi aldri berggrunns. Hættuhlutfall (HR) og 95% öryggismörk (CI) voru reiknuð þar sem leiðrétt var fyrir aldri, kyni, menntun, húsnæði, barneignum og reykingum. Niðurstöður: Á meðal útsetta hópsins var HR fyrir öll dánarmein 0,98 (95%CI 0,91-1,05) í samanburði við köld svæði (berggrunnur eldri en 3,3 miljón ár). HR fyrir krabbamein í brjósti var 1,53 (95%CI 1,04-2,24), blöðruhálskirtli 1,74 (95%CI 1,21-2,52), nýrum 1,78 (95%CI 1,03-3,07) og eitilæxlum öðrum en Hodgkin’s 2,01 (95%CI 1,05-3,38). HR fyrir inflú- ensu var 3,36 (95%CI 1,32-8,58) og fyrir sjálfsvíg 1,49 (95%CI 1,03-2,17). Ályktanir: Aukningin á hættu að deyja vegna krabbameins í brjóstum, blöðruhálskirtli og nýrum, og eitilæxla annarra en Hodgkin’s stað- festir niðurstöður fyrri nýgengisrannsókna meðal íbúa háhitasvæða og notenda jarðhitavatns. Áhættan er því ekki einungis bundin við krabba- mein með góðar horfur heldur varðar einnig banvæn krabbamein. Frekari rannsókna er þörf á efna- og eðlisfræðilegum þáttum jarðhita- vatns og umhverfisþáttum tengdum svæðunum.
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100
Qupperneq 101
Qupperneq 102
Qupperneq 103
Qupperneq 104
Qupperneq 105
Qupperneq 106
Qupperneq 107
Qupperneq 108
Qupperneq 109
Qupperneq 110
Qupperneq 111
Qupperneq 112
Qupperneq 113
Qupperneq 114
Qupperneq 115
Qupperneq 116
Qupperneq 117
Qupperneq 118
Qupperneq 119
Qupperneq 120
Qupperneq 121
Qupperneq 122
Qupperneq 123
Qupperneq 124
Qupperneq 125
Qupperneq 126
Qupperneq 127
Qupperneq 128
Qupperneq 129
Qupperneq 130
Qupperneq 131
Qupperneq 132
Qupperneq 133
Qupperneq 134
Qupperneq 135
Qupperneq 136
Qupperneq 137
Qupperneq 138
Qupperneq 139
Qupperneq 140
Qupperneq 141
Qupperneq 142
Qupperneq 143
Qupperneq 144
Qupperneq 145
Qupperneq 146
Qupperneq 147
Qupperneq 148
Qupperneq 149
Qupperneq 150
Qupperneq 151
Qupperneq 152
Qupperneq 153
Qupperneq 154
Qupperneq 155
Qupperneq 156
Qupperneq 157
Qupperneq 158
Qupperneq 159
Qupperneq 160
Qupperneq 161
Qupperneq 162
Qupperneq 163
Qupperneq 164
Qupperneq 165
Qupperneq 166
Qupperneq 167
Qupperneq 168
Qupperneq 169
Qupperneq 170
Qupperneq 171
Qupperneq 172
Qupperneq 173

x

Læknablaðið : fylgirit

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið : fylgirit
https://timarit.is/publication/991

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.